Study reveals challenges and risks for women using anabolic-androgenic steroids

A new study published in Drug and Alcohol Review has revealed critical insights into the challenges and risks faced by women who use anabolic-androgenic steroids (AAS).

FDA Adds Guillain-Barre Syndrome Warning to Two RSV Vaccines

The FDA issued a safety communication that warns about possible Guillain-Barré syndrome (GBS) with respiratory syncytial virus (RSV) vaccines manufactured by Pfizer (Abrysvo) and GSK

January 9, 2025

Pα+: Day 2 Dispatch from ‘Advancing Psychedelic Clinical Study Design’, Hosted by the Reagan-Udall Foundation for the FDA – Psychedelic Alpha

On January 31st and February 1st, the Reagan-Udall Foundation for the Food and Drug Administration hosted a two-day virtual meeting, Advancing Psychedelic Clinical Study Design. The below

February 16, 2024

What to know about Dr. Oz, Trump’s pick to head CMS

Good morning. What a newsy week. I’m Isabella Cueto, a chronic disease reporter at STAT, and so it’s my duty to say: Pause. Deep breath.

November 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.